AAAAAA
Results: 26-33/33
Authors:
Macdougall, IC
Citation: Ic. Macdougall, Nandrolone decanoate may be an adjuvant therapy to augment haemoglobin response today? Reply, NEPH DIAL T, 14(9), 1999, pp. 2258-2258
Authors:
Macdougall, IC
Citation: Ic. Macdougall, The role of ACE inhibitors and angiotensin II receptor blockers in the response to epoetin, NEPH DIAL T, 14(8), 1999, pp. 1836-1841
Authors:
Macdougall, IC
Ritz, E
Citation: Ic. Macdougall et E. Ritz, 2nd European Epoetin Symposium - Optimizing anaemia therapy in CRF - 17-19April 1998 Crete, Greece - Foreword, NEPH DIAL T, 14, 1999, pp. 1-1
Authors:
Macdougall, IC
Citation: Ic. Macdougall, Metabolic adjuvants to erythropoietin therapy, MIN ELECT M, 25(4-6), 1999, pp. 357-364
Authors:
Macdougall, IC
Chandler, G
Elston, O
Harchowal, J
Citation: Ic. Macdougall et al., Beneficial effects of adopting an aggressive intravenous iron policy in a hemodialysis unit, AM J KIDNEY, 34(4), 1999, pp. S40-S46
Authors:
Macdougall, IC
Citation: Ic. Macdougall, Strategies for iron supplementation: Oral versus intravenous, KIDNEY INT, 55, 1999, pp. S61-S66
Authors:
Breen, CP
Macdougall, IC
Citation: Cp. Breen et Ic. Macdougall, Correction of epoetin-resistant megaloblastic anaemia following vitamin B-12 and folate administration, NEPHRON, 83(4), 1999, pp. 374-375
Authors:
Macdougall, IC
Ritz, E
Citation: Ic. Macdougall et E. Ritz, The Normal Haematocrit Trial in dialysis patients with cardiac disease: are we any the less confused about target haemoglobin?, NEPH DIAL T, 13(12), 1998, pp. 3030-3033